The production of well characterized challenge material of BSL-3/4 viruses.
Active Awarded Last action
- Contract number
- 75N93022F00001
- Awardee
-
American Type Culture Collection UEI KT4MLLHK99V6
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,839,794
Award facts
- Contract value 85% obligated
-
- $2,839,793.88 Current, with exercised options
- $3,351,917.88 Potential, with all options
- Completion date 93% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Manassas, VA 20110, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $85,613 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $45,016 | |
| Funding Only Action | $137,287 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $55,067 | |
| Exercise an Option | $512,124 | |
| Other Administrative Action | $153,638 | |
| Exercise an Option | $468,816 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $455,161 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $497,208 | |
| Original award | $429,864 |
Show all 24
About this award
The National Institute of Allergy and Infectious Diseases issued a delivery order to American Type Culture Collection on January 17, 2022, for production of well-characterized challenge material of Biosafety Level 3 and 4 viruses, with a ceiling value of $3,351,917.88 under the In Vitro Assessments of Antimicrobial Activity (IVAAA) IDIQ.
Place of performance is Manassas, VA. The order is priced on a cost-plus-fixed-fee basis with an ultimate completion date of March 14, 2027.
Across fiscal years FY2022–FY2025, the order has invoiced $3 million against a labor footprint of 7.3 FTEs and 10,972 contractor hours. Government-paid hourly rates have trended upward from $200.28/hr in FY2022 to $294.66/hr in FY2023, stabilizing at approximately $291/hr in FY2024, before declining to $255.50/hr in FY2025. Most recent engagement (FY2025) reflects 0.2 FTEs and 353 hours with one subcontractor performing no subcontracted hours.
Quick answers
Who was awarded contract 75N93022F00001?
75N93022F00001 was awarded to American Type Culture Collection by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on January 17, 2022.
How much is contract 75N93022F00001 worth?
The government has obligated $2,839,794 on 75N93022F00001. Its potential value, with all options, is $3,351,918.
Is contract 75N93022F00001 an order under another contract?
Yes. 75N93022F00001 is a delivery order under 75N93019D00002, an indefinite delivery contract, on In Vitro Assessments of Antimicrobial Activity (IVAAA).
Was contract 75N93022F00001 competed?
The extent of competition for 75N93022F00001 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award